[Journal logo]

Volume 64 
Part 8 
Pages o1503-o1504  
August 2008  

Received 7 July 2008
Accepted 9 July 2008
Online 16 July 2008

Key indicators
Single-crystal X-ray study
T = 100 K
Mean [sigma](C-C) = 0.003 Å
R = 0.047
wR = 0.136
Data-to-parameter ratio = 23.6
Details
Open access

4-[(E)-2,6-Dichlorobenzylideneamino]-3-{1-[4-(2-methylpropyl)phenyl]ethyl}-1H-1,2,4-triazole-5(4H)-thione

aX-ray Crystallography Unit, School of Physics, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia,bCrystal Materials Research Unit, Department of Chemistry, Faculty of Science, Prince of Songkla University, Hat-Yai, Songkhla 90112, Thailand,cDepartment of Studies in Chemistry, Mangalore University, Mangalagangotri, Mangalore 574 199, India,dDepartment of Studies in Physics, Mangalore University, Mangalagangotri, Mangalore 574 199, India, and eDepartment of Chemistry, Nehru Arts & Science College, Kanhangad, Kerala 671 328, India
Correspondence e-mail: hkfun@usm.my

In the title Schiff base compound, C21H22Cl2N4S, the triazole ring makes dihedral angles of 2.15 (11) and 87.48 (11)° with the 2,6-dichlorophenyl and methylpropylphenyl rings, respectively. Weak intramolecular C-H...S and C-H...Cl interactions generate S(6) and S(5) ring motifs, respectively. In the crystal structure, centrosymmetrically related molecules are linked into dimers by N-H...S hydrogen bonds. These dimers are arranged into sheets parallel to the ab plane and are stacked along the c axis. C-H...[pi] interactions involving the methylpropylphenyl ring and [pi]-[pi] interactions involving the dichlorophenyl ring [centroid-centroid distance = 3.5865 (3) Å] are also observed.

Related literature

For related literature on hydrogen-bond motifs, see: Bernstein et al. (1995[Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.]). For bond-length data, see: Allen et al. (1987[Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-S19.]). For related structures, see: Fun et al. (2008a[Fun, H.-K., Jebas, S. R., Razak, I. A., Sujith, K. V., Patil, P. S., Kalluraya, B. & Dharmaprakash, S. M. (2008a). Acta Cryst. E64, o1076-o1077.],b[Fun, H.-K., Jebas, S. R., Sujith, K. V., Patil, P. S., Kalluraya, B. & Dharmaprakash, S. M. (2008b). Acta Cryst. E64, o1001-o1002.]). For background to the activities and applications of 1,2,4-triazole derivatives, see: Almasirad et al. (2004[Almasirad, A., Tabatabai, S. A., Faizi, M., Kebriaeezadeh, A., Mehrabi, N., Dalvandi, A. & Shafiee, A. (2004). Bioorg. Med. Chem. Lett. 14, 6057-6059.]); Al-Soud et al. (2003[Al-Soud, Y. A., Al-Masoudi, N. A. & Ferwanah, A. R. S. (2003). Bioorg. Med. Chem. 11, 1701-1708.]); Amir & Shikha (2004[Amir, M. & Shikha, K. (2004). Eur. J. Med. Chem. 39, 535-545.]); Holla et al. (2003[Holla, B. S., Veerendra, B., Shivananda, M. K. & Poojary, B. (2003). Eur. J. Med. Chem. 38, 759-767.]); Kawashima et al. (1987[Kawashima, Y., Ishikawa, H., Kida, S., Tanaka, T. & Masuda, T. (1987). Chem Abstr. 106, 138475x.]); Palaska et al. (2002[Palaska, E., Sahin, G., Kelicen, P., Durlu, N. T. & Altinok, G. (2002). Il Farmaco, 57, 101-107.]); Walczak et al. (2004[Walczak, K., Gondela, A. & Suwin'ski, J. (2004). Eur. J. Med. Chem. 39, 849-853.]); Zitouni et al. (2005[Zitouni, G. T., Kaplancíklí, Z. A., Yíldíz, M. T., Chevallet, P. & Kaya, D. (2005). Eur. J. Med. Chem. 40, 607-613.]).

[Scheme 1]

Experimental

Crystal data
  • C21H22Cl2N4S

  • Mr = 433.40

  • Triclinic, [P \overline 1]

  • a = 8.6190 (2) Å

  • b = 9.4441 (2) Å

  • c = 14.4244 (4) Å

  • [alpha] = 104.669 (2)°

  • [beta] = 95.492 (2)°

  • [gamma] = 110.418 (1)°

  • V = 1042.33 (5) Å3

  • Z = 2

  • Mo K[alpha] radiation

  • [mu] = 0.43 mm-1

  • T = 100.0 (1) K

  • 0.29 × 0.20 × 0.16 mm

Data collection
  • Bruker SMART APEXII CCD area-detector diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2005[Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.887, Tmax = 0.934

  • 19865 measured reflections

  • 6032 independent reflections

  • 4139 reflections with I > 2[sigma](I)

  • Rint = 0.050

Refinement
  • R[F2 > 2[sigma](F2)] = 0.046

  • wR(F2) = 0.136

  • S = 1.00

  • 6032 reflections

  • 256 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 0.59 e Å-3

  • [Delta][rho]min = -0.47 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

Cg1 is the centroid of the C1-C6 ring.

D-H...A D-H H...A D...A D-H...A
N2-H2A...S1i 0.86 2.44 3.2849 (19) 169
C10-H10A...Cl2 0.93 2.62 2.978 (2) 104
C10-H10A...S1 0.93 2.52 3.2066 (19) 131
C15-H15A...Cg1ii 0.93 2.94 3.793 (3) 154
Symmetry codes: (i) -x+2, -y-1, -z; (ii) -x+1, -y, -z.

Data collection: APEX2 (Bruker, 2005[Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: APEX2; data reduction: SAINT (Bruker, 2005[Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); program(s) used to solve structure: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2003[Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: CI2627 ).


Acknowledgements

KVS, BK and AM are grateful to Kerala State Council for Science Technology and Environment, Thiruvananthapuram, for financial assistance. The authors also thank Universiti Sains Malaysia for the Research University Golden Goose grant No. 1001/PFIZIK/811012.

References

Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-S19.
Almasirad, A., Tabatabai, S. A., Faizi, M., Kebriaeezadeh, A., Mehrabi, N., Dalvandi, A. & Shafiee, A. (2004). Bioorg. Med. Chem. Lett. 14, 6057-6059.  [CrossRef] [PubMed] [ChemPort]
Al-Soud, Y. A., Al-Masoudi, N. A. & Ferwanah, A. R. S. (2003). Bioorg. Med. Chem. 11, 1701-1708.  [CrossRef] [PubMed] [ChemPort]
Amir, M. & Shikha, K. (2004). Eur. J. Med. Chem. 39, 535-545.  [ISI] [CrossRef] [PubMed] [ChemPort]
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.  [CrossRef] [ChemPort] [ISI]
Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Fun, H.-K., Jebas, S. R., Razak, I. A., Sujith, K. V., Patil, P. S., Kalluraya, B. & Dharmaprakash, S. M. (2008a). Acta Cryst. E64, o1076-o1077.  [CSD] [CrossRef] [details]
Fun, H.-K., Jebas, S. R., Sujith, K. V., Patil, P. S., Kalluraya, B. & Dharmaprakash, S. M. (2008b). Acta Cryst. E64, o1001-o1002.  [CSD] [CrossRef] [details]
Holla, B. S., Veerendra, B., Shivananda, M. K. & Poojary, B. (2003). Eur. J. Med. Chem. 38, 759-767.  [ISI] [CrossRef] [PubMed]
Kawashima, Y., Ishikawa, H., Kida, S., Tanaka, T. & Masuda, T. (1987). Chem Abstr. 106, 138475x.
Palaska, E., Sahin, G., Kelicen, P., Durlu, N. T. & Altinok, G. (2002). Il Farmaco, 57, 101-107.  [CrossRef] [PubMed] [ChemPort]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.  [ISI] [CrossRef] [ChemPort] [details]
Walczak, K., Gondela, A. & Suwin'ski, J. (2004). Eur. J. Med. Chem. 39, 849-853.  [CrossRef] [PubMed] [ChemPort]
Zitouni, G. T., Kaplancíklí, Z. A., Yíldíz, M. T., Chevallet, P. & Kaya, D. (2005). Eur. J. Med. Chem. 40, 607-613.  [PubMed]


Acta Cryst (2008). E64, o1503-o1504   [ doi:10.1107/S1600536808021272 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.